Weight loss, in the context of medicine or health or physical fitness, is a reduction of the total body weight, due to a mean loss of fluid, body fat or adipose tissue and/or lean mass, namely bone mineral deposits, muscle, tendon and other connective tissue.
Want to lose weight? It might help to pour that diet soda down the drain. Diet drinks may actually make you put on weight rather than lose it. – Use of no-calorie sweeteners may make it harder for people to control their intake and body weight. Cutting the connection between sweets and calories may confuse the body, making it harder to regulate intake, revealed by researchers.
Changes in folate, vitamin B12 and homocysteine associated with incident dementia. – Folate deficiency is associated with a tripling in the risk of developing dementia among elderly people, suggests research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.
A new study gives the strongest evidence yet that obesity surgery can cure diabetes. Gastric banding is a medical procedure where a band is placed around a patient’s stomach to reduce appetite and food intake. – A new world-first study by Monash University researchers has found gastric banding surgery has a profound impact on one of society’s biggest health issues – diabetes. Obese patients with Type 2 diabetes who underwent gastric banding were five times more likely to have their diabetes go into long term remission, compared with patients who engaged in conventional weight loss therapies, such as a controlled calorie diet and exercise.
People who participate in a pedometer-based walking program can be expected to lose a modest amount of weight even without changing their diet, with more weight loss the longer they stick with the program, according to a University of Michigan Health System analysis of nine studies. – People walking regularly can expect a modest amount of weight loss even without changing their diet, with more weight loss the longer they stick with the walking program, revealed by researchers at the University of Michigan Health System, US.
Sorbitol intake should be considered in patients with bowel problems, chronic diarrhoea, and weight loss. – Severe weight loss was detected in patients due to chronic diarrhea after eating chewing gum and sweets because of excess sorbitol intake, a widely used sweetener in “sugar-free” products. Sorbitol has laxative properties and is poorly absorbed by the small intestine.
At the age of 18, most young women are embarking on adulthood without a care in the world?health included. But experts at UC say that shouldn?t always be the case. – University of Cincinnati UC experts urge women to watch for warning signs associated with heart disease, a condition that is becoming more common, especially among women.
Most experts agree thyroid function tests are generally unnecessary in an overweight child if he/she has normal linear growth and no other symptoms of hypothyroidism. The results of this study support this. – Children treated for hypothyroidism aren’t likely to drop pounds with treatment for the condition says a new study in the Journal of Pediatrics. The study is the first to examine the link between hypothyroidism treatment and weight loss in pediatric patients.
Gastric inhibitory polypeptide (GIP) hormone in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes. – A new study finds that a chemical found in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes in an animal model. The hormone is gastric inhibitory polypeptide (GIP) receptor blockade.
A new CSIRO study has found that overweight and obese men can lose weight effectively and safely on a high protein diet.
– Presenting the results of the study at the Nutrition Society Conference in Auckland, NZ, CSIRO dietitian Dr Manny Noakes said that the study suggests it is easier than previously thought for men to take action to lose weight.
Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. – The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.
